Topics

MEDICREA® Secures Several New Patents to Protect its Proprietary platform technology UNiD ASI

05:50 EDT 17 Jun 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implant...

Other Sources for this Article

MEDICREA®
Denys SOURNAC
Founder, Chairman and CEO
dsournac@medicrea.com

Fabrice KILFIGER
Chief Financial Officer
fkilfiger@medircrea.com
Tel: +33 (0)4 72 01 87 87

NEXT ARTICLE

More From BioPortfolio on "MEDICREA® Secures Several New Patents to Protect its Proprietary platform technology UNiD ASI"

Quick Search

Relevant Topic

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...